Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Community Health Equity Res Policy ; 44(3): 265-279, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-37202859

RESUMEN

A qualitative, community-engaged assessment was conducted to identify needs and priorities for infant obesity prevention programs among mothers participating in home visiting programs. Thirty-two stakeholders (i.e., community partners, mothers, home visitors) affiliated with a home visiting program serving low-income families during the prenatal to age three period participated in group level assessment sessions or individual qualitative interviews. Results indicated families face many challenges to obesity prevention particularly in terms of healthy eating. An obesity prevention program can address these challenges by offering realistic feeding options and non-judgmental peer support, improving access to resources, and tailoring program content to individual family needs and preferences. Informational needs, family factors in healthy eating outcomes, and the importance of access and awareness of programs were also noted. To ensure the cultural- and contextual-relevance of infant obesity prevention programs for underserved populations, needs and preferences among community stakeholders and the focal population should be used as a roadmap for intervention development.


Asunto(s)
Obesidad Infantil , Lactante , Femenino , Embarazo , Humanos , Obesidad Infantil/prevención & control , Evaluación de Necesidades , Madres , Pobreza , Consejo
2.
Ann Epidemiol ; 52: 26-34, 2020 12.
Artículo en Inglés | MEDLINE | ID: mdl-33010417

RESUMEN

PURPOSE: The purpose of this study was to examine how combinations of adverse childhood events (ACEs) contribute to the risk of postpartum depression and the mediating role of prenatal social support. METHODS: The Adverse Childhood Experiences Scale Questionnaire and the Edinburgh Postnatal Depression Scale Questionnaire were used to measure the study's exposure and outcome. Among a cohort of 419 mothers enrolled in a home visiting (HV) program, latent class analyses were used to identify classes of ACEs exposure. General linear models assessed the risk of postpartum depression, and prenatal social support was examined as a mediator. RESULTS: Four distinct classes of ACE exposure were identified. On the Edinburgh Postnatal Depression scale, mothers who were classified in Classes 1-3 scored higher by 2.6-4.4 points compared with women in Class 0. ACE class was found to be indirectly associated with postpartum depression scores through prenatal social support. CONCLUSIONS: Identifying combinations of ACEs in an HV program has the potential to improve the characterization of ACEs among low-income perinatal women in the United States. Elucidating how these combinations contribute to the risk of postpartum depression has the potential to identify women at increased risk, which can help HV programs prioritize prevention efforts.


Asunto(s)
Adultos Sobrevivientes de Eventos Adversos Infantiles/psicología , Experiencias Adversas de la Infancia/psicología , Maltrato a los Niños/psicología , Depresión Posparto/diagnóstico , Apoyo Social , Adulto , Adultos Sobrevivientes de Eventos Adversos Infantiles/estadística & datos numéricos , Experiencias Adversas de la Infancia/estadística & datos numéricos , Niño , Maltrato a los Niños/estadística & datos numéricos , Estudios de Cohortes , Depresión Posparto/epidemiología , Depresión Posparto/psicología , Femenino , Humanos , Acontecimientos que Cambian la Vida , Periodo Posparto , Atención Prenatal , Escalas de Valoración Psiquiátrica , Estudios Retrospectivos , Factores Socioeconómicos , Encuestas y Cuestionarios
3.
Cell Chem Biol ; 25(8): 1006-1016.e8, 2018 08 16.
Artículo en Inglés | MEDLINE | ID: mdl-29937406

RESUMEN

Viral envelope proteins are required for productive viral entry and initiation of infection. Although the humoral immune system provides ample evidence for targeting envelope proteins as an antiviral strategy, there are few pharmacological interventions that have this mode of action. In contrast to classical antiviral targets such as viral proteases and polymerases, viral envelope proteins as a class do not have a well-conserved active site that can be rationally targeted with small molecules. We previously identified compounds that inhibit dengue virus by binding to its envelope protein, E. Here, we show that these small molecules inhibit dengue virus fusion and map the binding site of these compounds to a specific pocket on E. We further demonstrate inhibition of Zika, West Nile, and Japanese encephalitis viruses by these compounds, providing pharmacological evidence for the pocket as a target for developing broad-spectrum antivirals against multiple, mosquito-borne flavivirus pathogens.


Asunto(s)
Antivirales/química , Antivirales/farmacología , Infecciones por Flavivirus/tratamiento farmacológico , Flavivirus/efectos de los fármacos , Proteínas del Envoltorio Viral/metabolismo , Internalización del Virus/efectos de los fármacos , Secuencia de Aminoácidos , Animales , Línea Celular , Secuencia Conservada , Virus del Dengue/química , Virus del Dengue/efectos de los fármacos , Virus del Dengue/fisiología , Descubrimiento de Drogas , Flavivirus/química , Flavivirus/fisiología , Infecciones por Flavivirus/metabolismo , Infecciones por Flavivirus/virología , Humanos , Simulación del Acoplamiento Molecular , Bibliotecas de Moléculas Pequeñas/química , Bibliotecas de Moléculas Pequeñas/farmacología , Proteínas del Envoltorio Viral/química , Replicación Viral/efectos de los fármacos , Virus Zika/química , Virus Zika/efectos de los fármacos , Virus Zika/fisiología
4.
Mol Immunol ; 43(9): 1349-57, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16216327

RESUMEN

Antagonism of T cell responses by variants of the cognate peptide is a potential mechanism of viral escape from immune responses and may play a role in the ability of HIV to evade immune control. We show here a rarely described mechanism of antagonism by a peptide shorter than the minimum length epitope for an HIV p24-specific CD4+ T cell clone. The shorter antagonist peptide-MHC complex bound the T cell receptor (TCR), albeit with lower affinity than the full-length agonist peptide. Prior work showing the crystal structure of the peptide-MHC complex revealed a unique glycine hinge near the C-terminus of the agonist peptide, allowing the generation of full-length antagonist peptide lacking the hinge. These results confirm the dependence of productive TCR engagement on residues spilling out from the C-terminus of the MHC binding groove and show that partial engagement of the TCR with a truncated, low-affinity ligand can result in T cell antagonism.


Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/virología , Proteína p24 del Núcleo del VIH/inmunología , Secuencia de Aminoácidos , Epítopos/química , Epítopos/inmunología , Proteína p24 del Núcleo del VIH/química , Proteína p24 del Núcleo del VIH/genética , Infecciones por VIH/inmunología , Infecciones por VIH/virología , Antígeno HLA-DR1/química , Antígeno HLA-DR1/metabolismo , Humanos , Técnicas In Vitro , Ligandos , Activación de Linfocitos , Modelos Moleculares , Datos de Secuencia Molecular , Complejos Multiproteicos , Fragmentos de Péptidos/química , Fragmentos de Péptidos/genética , Fragmentos de Péptidos/inmunología , Receptores de Antígenos de Linfocitos T/metabolismo
5.
J Prev Interv Community ; 34(1-2): 89-107, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17890195

RESUMEN

As home visitation programs go to scale, numerous challenges are faced in implementation and quality assurance. This article describes the origins and implementation of Every Child Succeeds, a multisite home visitation program in southwestern Ohio and Northern Kentucky. In order to optimize quality assurance and generate new learning for the field, a Web-based system (eECS) was designed to systematically collect and use data. Continuous quality assurance procedures derived from business and industry have been established. Findings from data collection have documented outcomes, and have identified clinical needs that potentially undermine the impact of home visitation. An augmented module approach has been used to address these needs, and a program to treat maternal depression is described as an example of this approach. Challenges encountered are also discussed.


Asunto(s)
Maltrato a los Niños/prevención & control , Servicios de Salud del Niño/normas , Medicina Comunitaria/normas , Salud de la Familia , Visita Domiciliaria , Desarrollo de Programa , Garantía de la Calidad de Atención de Salud , Calidad de la Atención de Salud , Adolescente , Adulto , Niño , Preescolar , Conducta Cooperativa , Femenino , Humanos , Internet , Relaciones Interprofesionales , Kentucky , Ohio , Evaluación de Resultado en la Atención de Salud , Evaluación de Programas y Proyectos de Salud
6.
Cell Chem Biol ; 23(4): 443-52, 2016 04 21.
Artículo en Inglés | MEDLINE | ID: mdl-27105280

RESUMEN

Dengue virus infects more than 300 million people annually, yet there is no widely protective vaccine or drugs against the virus. Efforts to develop antivirals against classical targets such as the viral protease and polymerase have not yielded drugs that have advanced to the clinic. Here, we show that the allosteric Abl kinase inhibitor GNF-2 interferes with dengue virus replication via activity mediated by cellular Abl kinases but additionally blocks viral entry via an Abl-independent mechanism. To characterize this newly discovered antiviral activity, we developed disubstituted pyrimidines that block dengue virus entry with structure-activity relationships distinct from those driving kinase inhibition. We demonstrate that biotin- and fluorophore-conjugated derivatives of GNF-2 interact with the dengue glycoprotein, E, in the pre-fusion conformation that exists on the virion surface, and that this interaction inhibits viral entry. This study establishes GNF-2 as an antiviral compound with polypharmacological activity and provides "lead" compounds for further optimization efforts.


Asunto(s)
Antivirales/farmacología , Virus del Dengue/efectos de los fármacos , Inhibidores de Proteínas Quinasas/farmacología , Proteínas Proto-Oncogénicas c-abl/antagonistas & inhibidores , Pirimidinas/farmacología , Animales , Antivirales/química , Virus del Dengue/metabolismo , Relación Dosis-Respuesta a Droga , Humanos , Ratones , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Células 3T3 NIH , Inhibidores de Proteínas Quinasas/química , Proteínas Proto-Oncogénicas c-abl/deficiencia , Proteínas Proto-Oncogénicas c-abl/metabolismo , Pirimidinas/química , Relación Estructura-Actividad , Proteínas del Envoltorio Viral/antagonistas & inhibidores , Proteínas del Envoltorio Viral/metabolismo
7.
J Virol ; 78(16): 8844-51, 2004 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15280492

RESUMEN

The immune correlates of protection in human immunodeficiency virus type 1 (HIV-1) infection remain poorly defined, particularly the contribution of CD4(+) T cells. Here we explore the effector functions of HIV-1-specific CD4(+) T cells. We demonstrate HIV-1 p24-specific CD4(+)-T-cell cytolytic activity in peripheral blood mononuclear cells directly ex vivo and after enrichment by antigen-specific stimulation. We further show that in a rare long-term nonprogressor, both an HIV-1-specific CD4(+)-T-cell clone and CD4(+) T cells directly ex vivo exert potent suppression of HIV-1 replication. Suppression of viral replication was dependent on cell-cell contact between the effector CD4(+) T cells and the target cells. While the antiviral effector activity of CD8(+) T cells has been well documented, these results strongly suggest that HIV-1-specific CD4(+) T cells are capable of directly contributing to antiviral immunity.


Asunto(s)
Linfocitos T CD4-Positivos/inmunología , VIH-1/inmunología , Linfocitos T Citotóxicos/inmunología , Linfocitos T Reguladores/inmunología , Linfocitos T CD4-Positivos/virología , Citotoxicidad Inmunológica , Proteína p24 del Núcleo del VIH/inmunología , Humanos , Leucocitos Mononucleares/inmunología , Replicación Viral/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA